The present invention provides methods of treating leukemia comprising administration of a resistance modulating amount of a compound having the formula (2r)-anti-5-{3-[4-(10,11-difluoromethano-dibenzosuber-5-yl)pipera- zin-1-yl]-2-hydroxypropoxy}quinoline 2.5 hydrochloride.